Mimedx (MDXG) Accumulated Expenses (2011 - 2026)

Mimedx has disclosed Accumulated Expenses across 16 years of filings, most recently posting $13.2 million for Q2 2026.

• In Q2 2026, Accumulated Expenses fell 40.18% year-over-year to $13.2 million; the TTM figure through Jun 2026 stood at $13.2 million (down 40.18% YoY), while the FY2025 annual figure was $31.1 million, up 31.26% from the prior year.
• Accumulated Expenses came in at $13.2 million for Q2 2026 at Mimedx, down from $14.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $31.1 million in Q4 2025 to a low of $13.2 million in Q2 2026.
• Average Accumulated Expenses over 5 years is $20.6 million, with a median of $20.5 million recorded in 2022.
• Year-over-year, Accumulated Expenses plunged 44.25% in 2022 and soared 37.08% in 2025.
• Over 5 years, Accumulated Expenses stood at $20.9 million in 2022, then gained by 7.18% to $22.4 million in 2023, then rose by 5.88% to $23.7 million in 2024, then jumped by 31.26% to $31.1 million in 2025, then tumbled by 57.59% to $13.2 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $13.2 million in Q2 2026, $14.5 million in Q1 2026, and $31.1 million in Q4 2025.